Transforming CAR-T Therapy
At GenCART, we are pioneering the next generation of CAR-T therapies to bring life-changing treatments for blood cancers and autoimmune disorders to patients everywhere.
We believe that advanced cellular therapies should not only be effective and safe, but also accessible and affordable.
Our Philosophy
Cost Revolution – By leveraging decentralized manufacturing and novel supply-chain efficiencies, we aim to reduce the cost of CAR-T by more than half, making treatment available to a broader patient population worldwide.
Innovative Focus – We specialize in CAR-T therapies designed for both hematologic malignancies and autoimmune diseases, expanding the promise of immunotherapy to conditions previously untreatable with cell therapy.
Safety First – Our platforms integrate precision engineering and rigorous clinical oversight to reduce toxicity risks such as cytokine release syndrome and neurotoxicity, ensuring a safer patient journey.
1+